Stay updated on Flotetuzumab EAP in AML: Investigational Clinical Trial
Sign up to get notified when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.

Latest updates to the Flotetuzumab EAP in AML: Investigational Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page footer’s system revision/version indicator was updated from v3.5.0 to v3.5.3, reflecting a platform update with no change to the study’s record contents.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the record history.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision v3.4.3 to the study record history. Removed Revision v3.4.2.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision entry (v3.4.2) was added to the record history and the previous revision (v3.4.1) was removed.SummaryDifference0.1%

- Check92 days agoChange DetectedA new revision entry (v3.4.1) was added to the study record history, replacing the prior v3.4.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page now includes UI explanations for how changes are highlighted (green additions, red deletions) and a glossary toggle, and the revision label was updated from v3.3.4 to v3.4.0.SummaryDifference1%

Stay in the know with updates to Flotetuzumab EAP in AML: Investigational Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.